AbbVie Inc. (NYSE:ABBV) discovers, develops, manufactures, and sells pharmaceuticals worldwide. It is set to report its Q3 ...

Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological ...

The Mayo Business Awards will take place next week. The annual event, which recognises the fine businesses the county has to ...

On Thursday, AbbVie Inc (ABBV) stock saw a modest uptick, ending the day at $189.65 which represents a slight increase of $1.77 or 0.94% from the prior close of $187.88. The stock opened at $188.43 ...

AbbVie, a global, research-driven biopharmaceutical company, organized a visit to its R&D facilities—the AbbVie Cambridge ...

Dividend stocks can be valuable investments for retirees who want a consistent stream of income flowing into their portfolio ...

AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 ...

Argent Capital Management LLC reduced its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 96.3% in the 3rd quarter, ...

Failed to import article template. Reason: Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app ...

Phillips Edison & Company, Inc. (Nasdaq: PECO) ("PECO" or the "Company"), one of the nation's largest owners and operators of high-quality grocery-anchored ...

Half a million people across the UK, of whom I am one, live day in day out with Inflammatory Bowel Disease (IBD). IBD is a ...